6 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
and CKD. ... in HFrEF on GDMT ... outcomes in HFrEF ... on GDMT, with or ... SGLT2 #inhibitors #EBM
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
angiotensin-receptor blocker; CAD ... ejection fraction; GDMT ... heart failure; HFpEF ... ejection fraction; HFrEF ... #CHF #Congestive
Pathophysiological mechanisms of diastolic heart failure HFpEF and possible therapeutic interventions.
Hypertension → Overload
Diabetes → Oxidative stress,
heart failure HFpEF ... RAGE activation CAD ... regulatory reserve → Pulmonary ... #heartfailure #dchf ... #hfpef #pathophysiology
Iron Deficiency in Heart Failure
Pathophysiology:
Chronic heart failure leads to an increase in inflammatory cytokines → Inflammation
functional ID) Treatment ... mortality and CV ... #deficiency #CHF ... #HFrEF #heartfailure ... diagnosis #management #cardiology
Heart Failure with Preserved Ejection Fraction: Management Principles

General Therapeutic Principles:
Reduce the congestive state 
 - Caution
Principles: Reduce the congestive ... hypertension, pulmonary ... #Management #Cardiology ... #HFpEF #dCHF #Diastolic ... #Treatment #HeartFailure
Severe Heart Failure & Cardiogenic Shock - Management Checklist 
Evaluation 
 - EKG & echocardiography
another option in HFrEF ... milrinone) for HFrEF ... With chronic AF, HFrEF ... #Checklist #CHF ... #HeartFailure #Cardiology